Drug Overdose
Conditions
Brief summary
It was a randomised intervention study, with before-and-after outcome measures and a control group, in patients who had an active long-term prescription for PPIs at high doses for at least 6 months.
Detailed description
The intervention consisted of sending patients an informative letter by post, in which their doctor invited them to seek an appointment for a medication review. Control group patients did not receive such a letter, and they were treated as usual (their doctors received a list of identifiers of patients on high doses). The main outcome variable was the number of active prescriptions of each PPI dose (high dose/standard dose/treatment cessation) at 6 months after the intervention.
Interventions
OTHERLetter by post to patients
Patients received an informative letter by post, in which their doctor invited them to seek an appointment for a medication review
Sponsors
Osakidetza
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients under the care of our organisation who in May 2017 had an active long-term prescription for PPIs at high doses for at least 6 months.
Exclusion criteria
* Patients whose GPs declined to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Active prescriptions of each proton pump inhibitors dose after the intervention | 6 months | Number of active prescriptions of each proton pump inhibitors dose (high dose/standard dose/treatment cessation) at 6 months after the intervention |
Countries
Spain
Outcome results
None listed